Dyne Therapeutics, Inc. - Common Stock (DYN)

CUSIP: 26818M108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
164,426,217
Total 13F shares
111,635,776
Share change
-923,077
Total reported value
$2,630,327,572
Put/Call ratio
378%
Price per share
$23.56
Number of holders
199
Value change
-$39,471,758
Number of buys
97
Number of sells
96

Security key

26818M108

Report period

Q4 2024

Institutions

199

Top holders

10

Top shareholders of DYN - Dyne Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
5.5%
9,026,697
$324,238,955 30 Sep 2024
13F
Atlas Venture Life Science Advisors, LLC
13F
Company
4.9%
8,020,136
$288,083,285 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
4.7%
7,794,114
$279,964,574 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
4.2%
6,864,137
$246,559,801 30 Sep 2024
13F
RTW INVESTMENTS, LP
13F
Company
4.1%
6,818,641
$244,925,585 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
4.1%
6,813,163
$244,755,389 30 Sep 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
3.9%
6,381,144
$229,210,692 30 Sep 2024
13F
FCPM III SERVICES B.V.
13F
Company
3.6%
5,954,069
$213,870,158 30 Sep 2024
13F
STATE STREET CORP
13F
Company
2.2%
3,641,859
$130,815,575 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
2%
3,282,000
$117,889,440 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.8%
2,939,340
$105,581,093 30 Sep 2024
13F
TCG Crossover Management, LLC
13F
Company
1.6%
2,650,150
$95,193,388 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.6%
2,636,293
$94,697,000 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.5%
2,402,972
$86,314,754 30 Sep 2024
13F
Venrock Adviser, LLC
13F
Company
1.3%
2,173,913
$78,086,955 30 Sep 2024
13F
Holocene Advisors, LP
13F
Company
1.2%
1,982,640
$71,216,429 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
1,859,413
$66,802,052 30 Sep 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.82%
1,346,952
$48,382,516 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.82%
1,342,500
$44,718,675 30 Sep 2024
13F
First Light Asset Management, LLC
13F
Company
0.76%
1,257,285
$45,161,677 30 Sep 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.74%
1,217,170
$43,720,746 30 Sep 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.7%
1,155,204
$41,494,928 30 Sep 2024
13F
Siren, L.L.C.
13F
Individual
0.69%
1,134,664
$40,757,131 30 Sep 2024
13F
Vivo Capital, LLC
13F
Company
0.68%
1,114,960
$40,049,363 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.64%
1,053,262
$37,833,171 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.59%
977,440
$35,109,645 30 Sep 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.55%
900,190
$32,334,825 30 Sep 2024
13F
Sofinnova Investments, Inc.
13F
Company
0.47%
772,070
$27,732,754 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.44%
721,502
$25,916,351 30 Sep 2024
13F
Man Group plc
13F
Company
0.44%
718,650
$25,813,908 30 Sep 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.44%
718,144
$25,795,732 30 Sep 2024
13F
ORBIMED ADVISORS LLC
13F
Company
0.43%
708,400
$25,445,728 30 Sep 2024
13F
MPM ASSET MANAGEMENT LLC
13F
Company
0.42%
682,376
$24,510,946 30 Sep 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
0.41%
672,096
$24,141,688 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.41%
670,484
$24,083,785 30 Sep 2024
13F
Avoro Capital Advisors LLC
13F
Company
0.4%
650,000
$23,348,000 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.39%
648,652
$23,299,580 30 Sep 2024
13F
UBS Group AG
13F
Company
0.38%
625,719
$22,475,827 30 Sep 2024
13F
EcoR1 Capital, LLC
13F
Company
0.34%
555,644
$19,958,732 30 Sep 2024
13F
Rock Springs Capital Management LP
13F
Company
0.28%
461,028
$16,560,126 30 Sep 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.26%
435,653
$15,648,656 30 Sep 2024
13F
NORGES BANK
13F
Company
0.26%
432,327
$15,529,186 30 Sep 2024
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.26%
428,000
$15,373,760 30 Sep 2024
13F
Vida Ventures Advisors, LLC
13F
Company
0.25%
407,499
$14,637,364 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
0.24%
390,956
$14,042,510 30 Sep 2024
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.2%
332,277
$11,935,390 30 Sep 2024
13F
WASATCH ADVISORS LP
13F
Company
0.2%
324,099
$11,641,636 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.19%
312,752
$11,234,052 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.19%
304,705
$10,324,416 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.18%
291,712
$10,478,295 30 Sep 2024
13F

Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q4 2024

As of 31 Dec 2024, Dyne Therapeutics, Inc. - Common Stock (DYN) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 111,635,776 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, FMR LLC, BlackRock, Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., RTW INVESTMENTS, LP, STATE STREET CORP, and CITADEL ADVISORS LLC. This page lists 199 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
200
Q4 2024 holders
199
Holder diff
-1
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .